ArticleFrontiers in pharmacology2022

Riboflavin for COVID-19 Adjuvant Treatment in Patients With Mental Health Disorders: Observational Study.

R A Akasov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.